American Kidney Fund’s Rare Kidney Disease Advocacy Day on Capitol Hill Seeks to Gather Support for Legislation that will Increase Awareness and Treatment of Rare Kidney Diseases
18 sept. 2024 09h59 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Members of AKF’s Rare Kidney Disease Action Network (RKDAN) and health care professionals will visit Capitol Hill in Washington, D.C. today to meet...
American Kidney Fund Hosts Annual National Summit on Unknown Causes of Kidney Disease
16 sept. 2024 09h49 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- As part of its ongoing groundbreaking work to advance understanding and patient care of undiagnosed or misdiagnosed causes of kidney disease, the...
Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024
16 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
05 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
03 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership Program at ‘Champion’ Level
27 août 2024 11h01 HE
|
American Kidney Fund
ROCKVILLE, Md., Aug. 27, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2024 class in AKF’s Corporate...
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
14 août 2024 07h10 HE
|
Unicycive Therapeutics, Inc.
– On Track to Submit OLC New Drug Application (NDA) by End of August 2024 – LOS ALTOS, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company”...
American Kidney Fund Receives Major Gift from Schattner Foundation to Support Grant Programs and National Virtual Camp
22 juil. 2024 09h01 HE
|
American Kidney Fund
ROCKVILLE, Md., July 22, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has received a $275,000 grant from Rockville-based Schattner Foundation to support AKF’s work on behalf of the 1 in 7...
New Guidelines from the American Kidney Fund Will Help People with Chronic Kidney Disease Manage High Potassium
11 juil. 2024 09h43 HE
|
American Kidney Fund
ROCKVILLE, Md., July 11, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched patient-focused guidelines to help people with chronic kidney disease (CKD) manage and treat...
American Kidney Fund Teams Up with Olympic Champion Suni Lee to Help Educate and Empower People to Know the Cause of Their Kidney Disease
09 juil. 2024 10h00 HE
|
American Kidney Fund
ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Reigning Olympic all-around gymnastics champion Suni Lee and the American Kidney Fund (AKF) announced today they are partnering for AKF’s Know Your...